Atom Investors LP Cullinan Oncology, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$10.2 - $11.91 $131,743 - $153,829	12,916 Added 12.05%	120,109 $1.23 Million
Q4 2022 Feb 14, 2023	BUY	$9.72 - $13.62 $255,849 - $358,505	26,322 Added 32.55%	107,193 $1.13 Million
Q3 2022 Nov 08, 2022	SELL	$11.82 - $15.42 $189,226 - $246,858	-16,009 Reduced 16.52%	80,871 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $13.55 $708,192 - $1.31 Million	96,880 New	96,880 $1.24 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.